Chief - Division of Hematology, Bone Marrow Transplant, and Cellular Therapy
| Company/Institution: |
University of Alabama at Birmingham (UAB) School of Medicine |
| Location: |
Birmingham, AL, USA |
| Degree Requirements: |
MD |
Salary: |
Not available |
| Job Type: |
Faculty |
Posted: |
November 12, 2024 |
| Job Setting: |
Medical School |
Application Period: |
November 12, 2024-January 12, 2025 |
Position Summary
The University of Alabama at Birmingham (UAB) School of Medicine seeks a distinguished physician-leader to serve as the Chief of the Division of Hematology and Associate Director of Translational Research at the UAB O’Neal Comprehensive Cancer Center. This role requires a dynamic leader with a robust background in hematologic malignancies. The successful candidate will oversee a rapidly growing division encompassing over 25 faculty members, and multiple cutting-edge programs including CAR-T and Bone Marrow Transplant (BMT).
Key Responsibilities
· Lead and expand the clinical, research, and educational missions of the Division of Hematology.
· Oversee strategic planning and implementation to advance the division’s goals in patient care, research, and education.
· Foster an environment of excellence in patient care, clinical research, and education.
· Collaborate with other departments and leaders within the UAB Health System to integrate and enhance cancer care across the institution.
· Manage faculty recruitment, development, and retention.
· Ensure optimal allocation of resources across the division.
· Represent the division and cancer center in national and international forums.
· Enhance the division’s impact through publications and leadership in clinical trials.
Required Qualifications
· MD or equivalent with board certification in Hematology and/or Medical Oncology.
· Demonstrated leadership experience in academic medicine and management of a large division or program.
· Proven track record of research in hematologic malignancies, with substantial peer-reviewed extramural funding.
· Strong commitment to mentoring and development of faculty, fellows, and residents.
· Excellent interpersonal and communication skills.
Desirable Qualifications
· Experience in translational research with a focus on hematologic malignancies.
· Leadership roles in national hematology/oncology societies.
Division of Hematology & Oncology
The UAB Division of Hematology and Oncology is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, and comprehensive training programs, we're dedicated to delivering the most advanced care.
The Division of Hematology/Oncology at the University of Alabama at Birmingham is committed to clinical excellence and improving patient outcomes through high-quality, multidisciplinary care. We also conduct world-class, cutting-edge laboratory research and clinical trials, as well as develop new therapies. In addition, our fellowship program continues to train tomorrow’s specialists, producing outstanding graduates who are proud to call UAB home.
Blood Marrow Transplantation & Cellular Therapy Program
Blood and Marrow Transplantation and Cellular Therapy Program
About the Program
Treating blood disorders and cancers cannot be done alone. It requires the strong will of a patient, the support of a family, and the compassion and expertise of a world-renowned health care team.
Since the UAB Bone Marrow Transplantation and Cell Therapy Program opened in 1991, we have dedicated each day to lead with innovation and serve with compassion, along with the most advanced treatment methods in a comfortable, cutting–edge facility. Each patient is treated by a team of healthcare professionals dedicated to providing outstanding care throughout the transplant process. The program is constantly building a work environment of professionalism where each person is valued and respected. The sole focus is ensuring the best possible results, the greatest quality of life, and the hope for a healthier future. Here at the UAB Bone Marrow Transplant Program, we celebrate life every day.
BMT
The BMT unit provides both autologous and allogeneic stem cell transplants, including haploidentical and umbilical cord transplants if necessary, and our program leads the nation in high-risk AML transplants. Our unit is staffed with physicians, pharmacists, nurses, nurse practitioners, clinical care coordinators, transplant coordinators, patient care technicians, research/data staff, social workers, nutritionists, and support staff who are dedicated to provide the best care for patients throughout the transplant process.
Comprehensive Sickle Cell Center
Targeting sickle cell disease to relieve suffering and enhance the quality of life for patients andtheir families.
Founded in 1983, the UAB Comprehensive Sickle Cell Center brings together scholars and researchers working in the forefront of basic, translational and clinical research, with the overarching goals to discover new ways to treat patients with sickle cell disease.
The Comprehensive Sickle Cell Center performs cutting edge research—supported by both NIH and industry funding—in five networked clinic sites across the state.
The Comprehensive Sickle Cell Center has led multiple clinical research studies, many of which have already been translated into improved patient care for this population. The principal investigators in the Center are in constant pursuit of knowledge that will provide improved therapies and ultimately cure this genetic disease.
We actively engage with community partners across Alabama to promote rural outreach, access, and patient education.
In addition to research and patient care activities conducted with outside hospitals and clinics, UAB has long-standing relationships with local community-based organizations that work closely with our sickle cell program to ensure patients remain faithful to their care plans.
Hematology & Oncology Research Areas
Cancer Cell Regulation
We have extensive expertise in diverse aspects of cancer cell biology including DNA replication and repair, epigenetics, RNA biology, metabolism and cell signaling. Projects focus on emerging research areas including cancer stem cell analysis, single cell transcriptomic, epigenomic and proteomic analysis, chromatin structure analysis, RNA splicing and regulation, and tumor bioenergetics.
Tumor Microenvironment
Our faculty and trainees study bidirectional interactions of cancer cells with their microenvironment, including the role of inflammatory factors and signals, and of immune cells, in regulating cancer cell growth, cancer progression and response to therapy. We collaborate to capitalize on the strengths of the UAB Program in Immunology to characterize immune and inflammatory responses to tumors.
Cancer Therapeutics
The Division explores mechanisms of resistance to cancer treatment, factors determining response and resistance of individual cancers to treatment (precision medicine), identification of novel targets and development of novel therapeutic strategies and cancer chemoprevention (a particular strength in our institution). Our program profits from many unique resources, such as the UAB cyclotron and advanced imaging facility, the Pharmacometrics core, and the Alabama Drug Development Initiative. Specifically, the ADDI is a consortium between UAB and the Southern Research Institute (SR), which supports identification of cancer therapeutic candidates against novel targets using SR’s expertise in library screening and chemistry, and the clinical trials and phase one unit of the O'Neal Comprehensive Cancer Center at UAB.
Cancer Outcomes
A particular strength is our investigation of factors determining cancer outcomes across all diseases, all ages and across the entire trajectory of disease. Faculty and trainees enjoy the considerable expertise and resources of the Institute for Cancer Outcomes and Survivorship, and UAB's overall strength in conducting outcomes research.
Hematologic Disorders
The UAB Comprehensive Sickle Cell Center has led multiple clinical research studies, many of which have already been translated into improved patient care for this population. The principal investigators in the Center are in constant pursuit of knowledge that will provide improved therapies and ultimately cure this genetic disease. Our benign hematology physicians are expert at managing all types of blood, bleeding and clotting disorders.
About the Employer
University of Alabama at Birmingham (UAB)
The University of Alabama at Birmingham (UAB): is a research university and academic health center that discovers, teaches, and applies knowledge for the intellectual, cultural, social, and economic benefit of Birmingham, the state, and beyond. UAB is internationally renowned for its intensely collaborative culture that has — for more than five decades — produced breakthroughs in education, health care, research, and service. UAB was ranked #1 in the United States, and in the top 10 worldwide, in the Times Higher Education World University Rankings, 2018 Young University Rankings.
UAB Medicine
UAB Medicine is the third largest public academic medical center in the country, with more than 1,900 beds and almost 18,000 employees. UAB Hospital is the eighth largest hospital in the nation, the flagship of the UAB Health System and the teaching hospital for the UAB School of Medicine. Situated among major research centers and clinics, UAB Hospital provides patients with a complete range of primary and specialty care services, as well as the most up-to-date treatments and innovations in health care. In addition to UAB Hospital, UAB Medicine includes The Kirklin Clinic of UAB Hospital, UAB Callahan Eye Hospital, as well as several primary and specialty care clinics, a dozen member and affiliate hospitals within Alabama, more than 10 cancer associates in the Southeast, and the Viva Health HMO.
UAB Hospital is ranked year after year as Alabama’s top Hospital by US News and World Report with top ranked specialties, the only Magnet Nursing-designated adult hospital in Alabama and a destination for comprehensive care for the people of Alabama and the surrounding region.
How to Apply
How To Apply
The University of Alabama has retained the services of Academic Med to assist with this strategically important search. The search for this esteemed position is being conducted by Academic Med Principals, Gentry Zacheis & Jim Hagood. Interested candidates should submit their curriculum vitae, a cover letter, and three references to Jim Hagood, Managing Principal, at jim@academic-med.com. All inquiries, nominations, and applications will be handled with confidentiality.
Contact Information
Jim Hagood
6900 Dallas Pkwy
Suite 300
Plano, TX 75024 USA
https://academic-med.com/job/chief-division-of-hematology-bone-marrow-transplant-and-cellular-therapy/
jim@academic-med.com
back to top